Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient.
about
Herpes zoster in Germany: quantifying the burden of diseaseVaccination against herpes zoster in developed countries: state of the evidenceEvaluation of efficacy and effectiveness of live attenuated zoster vaccineReducing the burden of Herpes Zoster in ItalyThe 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its UseThe impact of herpes zoster and post-herpetic neuralgia on quality-of-life.Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study.A review of topical high-concentration L-menthol as a translational model of cold allodynia and hyperalgesia.Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany.Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort.Evaluation of the economic burden of Herpes Zoster (HZ) infection.Increasing trends of herpes zoster in Australia.Communication gaps between physicians and patients with postherpetic neuralgia: results from a national study on practice patterns.Immunogenicity and safety of ZOSTAVAX(®) approaching expiry potency in individuals aged ≥50 years.5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability.Tolerability and safety of gastroretentive once-daily gabapentin tablets for the treatment of postherpetic neuralgia.A novel case of resolved postherpetic neuralgia with subsequent development of trigeminal neuralgia: a case report and review of the literature.Postherpetic neuralgia in the elderly.Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax®) in individuals aged ≥ 70 years: a randomized study of a single dose vs. two different two-dose schedules.Herpes Zoster and Postherpetic Neuralgia: a review of the effects of vaccination.Association between work time loss and quality of life in patients with Herpes Zoster: a pooled analysis of the MASTER studies.Shingles (herpes zoster) vaccine (zostavax(®)): a review of its use in the prevention of herpes zoster and postherpetic neuralgia in adults aged ≥50 years.Herpes zoster and the search for an effective vaccine.Treatment of postherpetic neuralgia with 5% lidocaine medicated plaster in elderly patients - subgroup analyses from three European clinical trials.Implanting iodine-125 seeds into rat dorsal root ganglion for neuropathic pain: neuronal microdamage without impacting hind limb motion.Treating shingles (herpes zoster) in the older person.Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu miceLocal Injection of Methylcobalamin Combined with Lidocaine for Acute Herpetic Neuralgia.Interventions to Improve Medicines Management for People with Dementia: A Systematic Review.5% lidocaine medicated plaster in elderly patients with postherpetic neuralgia: results of a compassionate use programme in France.A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile
P2860
Q21261833-B0DE8985-96C6-4E51-BF68-42D9DCF2DCD8Q26862748-BA598902-6F07-49B9-B124-4616ADDCFC66Q26866473-8ECD5988-CE0C-4357-B292-8660BEB963B4Q26998625-9CAC1AEE-6B62-4EDC-8325-A246DA6B44ABQ28069535-5D3A53AF-65B6-4FB6-8BE3-E16EFF242039Q33611436-27EC6627-DEE5-4EE7-A6B7-8488B64F32DCQ34064838-1D92B0E7-C2FF-48F2-B79E-66CDFAB1AF89Q34365482-9EC29373-B630-45DD-8595-FF193894112DQ35000186-657A98F1-2432-405B-A8E5-0CFC7BB4B043Q35141927-A257E551-4FF4-45A3-9F51-2A1C636055A1Q35498396-9399AB86-0AED-4B64-A2A9-C4085EA4D246Q35558494-CD540642-643B-4878-8573-AF8B7CEEC4D8Q35666349-2A41BCAA-6507-477E-8AA8-42179F41EF09Q35667362-82DE7318-1CE0-4944-80D5-C3ED2BC46C5AQ35752545-726956B8-9644-4379-BD13-BBFAE202C619Q36084684-E46A917E-1237-4B46-ADA2-15D840B6EF2BQ37101135-EDAF9E45-FEDF-46BB-BA12-AE76198F013AQ37427315-991A178D-C35F-4058-910C-D33235D0FFFEQ37521902-1C5AE977-E8D4-478F-91DF-9BD69CC31B38Q37538386-176AF76C-215D-466A-9EF1-B7DD10D81F36Q37591630-ADED39E3-5496-450D-9C22-EC15A67BDB82Q38120494-89474246-901C-49BC-BB0F-B418B6CB8C07Q38831062-2B730DFB-3CFE-4AD8-8547-DFD284863594Q39051182-5DD65B11-4110-4404-BEB2-C2270730E84DQ39201411-34BE4044-2B0D-45C0-9172-D041E14F85DAQ39836200-C1A41391-6F46-471E-949E-14D79C1433A7Q40444868-667B5E95-5ECB-4693-B8E2-56E54312E0EFQ47598111-1024FF01-FB34-4F99-A340-66DEC39D5B23Q47816321-E9BD074F-8EFD-4159-986A-B95DC08E99A0Q48231410-904AFEC2-ED7E-4393-8378-7CC8AB7423D8Q56888201-ACF02821-4306-4B32-9633-A8D67528639A
P2860
Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient.
@en
Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient.
@nl
type
label
Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient.
@en
Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient.
@nl
prefLabel
Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient.
@en
Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient.
@nl
P2093
P2860
P1433
P1476
Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient.
@en
P2093
Gunnar Wasner
Patricia Saddier
Ralf Baron
Robert W Johnson
P2860
P304
P356
10.2165/0002512-200825120-00002
P577
2008-01-01T00:00:00Z
P6179
1007622925